ChromaDex rebrands as Niagen Bioscience; Nasdaq ticker becomes NAGE

Niagen Bioscience, Inc.

Name change from ChromaDex Corporation to Niagen Bioscience, Inc. effective March 19, 2025.
Common stock begins trading under new ticker symbol 'NAGE' on Nasdaq; CUSIP unchanged.
Rebranding reflects focus on flagship Niagen ingredient and NAD+ healthy-aging science; no operational changes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.